Back to Journals » OncoTargets and Therapy » Volume 11

Crizotinib presented with promising efficacy but for concomitant mutation in next-generation sequencing-identified ROS1-rearranged non-small-cell lung cancer

Total article views   HTML views PDF downloads Totals
9,468 Dovepress* 8,455+ 904 9,359
PubMed Central* 1,013 354 1,367
Totals 9,468 1,258 10,726
*Since 15 October 2018
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 1 0 5

View citations on PubMed Central and Google Scholar